Cherry as expert at the French Parliament with Cedric Villani
Together with our ecosystem at the NBIC valley, we were asked to particiate as expert on
Get a better understanding and prediction for pre-clinical drug trials
Allowing comprehension and predicting of human responses earlier, while also offering ethical alternatives to animal testing.
Together with our ecosystem at the NBIC valley, we were asked to particiate as expert on
Solid tumors are characterized by areas of hypoxic tissue heterogeneously distributed inside the tumor mass. Hypoxia
Organs-on-Chip for Drug Development A drug should pass the preclinical evaluation phase to be FDA-approved. This
Drug induced liver injury (DILI)is one of the major reasons of drug attrition and it mainly
[vc_column][vc_row_inner][vc_column_inner width=”2/3″][vc_column_text] Liver is a fundamental organ for human life. It is responsible for macromolecules (carbohydrates,
Immune checkpoint modulation in renal cell carcinoma In this paper, Bedke and colleague highlight the way that patients treated for
Immune Checkpoint Modulators as an emerging therapy Through this paper, Kim and colleagues highlight the way
Immune Checkpoint modulators Check Point modulator validation system dedicated system to cell-cell interactions follow-up Summary | Immune Checkpoint
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity In this paper, Anagnostou and colleagues “discuss endpoints used in
The Challenge for Development of Valuable Immuno-oncology Biomarkers. In this paper, Mehnert JM and colleagues discussed the
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com